ImportRefusal LogoImportRefusal

PURE AND CURE HEALTHCARE PVT LTD

⚠️ Moderate Risk

FEI: 3016580955 • Haridwar • INDIA

FEI

FEI Number

3016580955

📍

Location

Haridwar

🇮🇳

Country

INDIA
🏢

Address

Plot No 26a Sector 8a R, , Haridwar, , India

Moderate Risk

FDA Import Risk Assessment

47.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
3
Unique Violations
2/15/2023
Latest Refusal
4/24/2017
Earliest Refusal

Score Breakdown

Violation Severity
80.0×40%
Refusal Volume
31.3×30%
Recency
27.5×20%
Frequency
10.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
2/15/2023
66SCA03BETAHISTINE HCL (VASODILATOR)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/6/2022
66RDY08BRINZOLAMIDE (VASOCONSTRICTOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/20/2020
61TDY31DOMPERIDONE
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2019
61TDB31DOMPERIDONE
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/24/2019
61XAA45CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/24/2017
61FCA55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is PURE AND CURE HEALTHCARE PVT LTD's FDA import refusal history?

PURE AND CURE HEALTHCARE PVT LTD (FEI: 3016580955) has 6 FDA import refusal record(s) in our database, spanning from 4/24/2017 to 2/15/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. PURE AND CURE HEALTHCARE PVT LTD's FEI number is 3016580955.

What types of violations has PURE AND CURE HEALTHCARE PVT LTD received?

PURE AND CURE HEALTHCARE PVT LTD has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about PURE AND CURE HEALTHCARE PVT LTD come from?

All FDA import refusal data for PURE AND CURE HEALTHCARE PVT LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.